FWD Group (1828) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
18 Mar, 2026Executive summary
New business sales rose 37% year-over-year to $1,935m for the nine months ended 30 September 2025, with broad-based growth across most Asian markets.
Over 40 new products were introduced in 2025, addressing evolving customer needs in protection, health, and savings.
Financial highlights
New business performance reached $1,935m, up 37% at constant exchange rates (CER) and 40% at actual exchange rates (AER) compared to 9M 2024.
Annualised premium equivalent (APE) was $1,158m, up 27% CER and 31% AER year-over-year.
Value of new business (VNB) reached $748m, up 17% CER and 20% AER year-over-year.
NB CSM margin was 60.6%, down 3.5 percentage points year-over-year.
VNB margin declined to 38.7%, down 6.7 percentage points year-over-year.
Outlook and guidance
Management expects continued momentum from diversified product offerings and multi-channel strategies, with ongoing benefits from visiting customers and wealth flows, especially in Hong Kong.
Continued strength in new business sales is expected for the remainder of 2025, though margin pressure is anticipated to persist, especially in Thailand due to low interest rates.
Medium-term new business sales growth rates are expected to moderate, but long-term growth and value creation remain a focus, supported by diversified distribution and digital tools.
Latest events from FWD Group
- Record-breaking growth, margin strength, and digital innovation drive robust 2025 results.1828
Q4 2025 (Q&A)18 Mar 2026 - Record new business growth, strong capital, and digital innovation drive robust results.1828
Q2 202518 Mar 2026 - Record-breaking 2025 profit, 25% APE growth, and strong gains in Hong Kong and emerging markets.1828
Q4 202518 Mar 2026 - Record new business growth and strong capital position following successful IPO.1828
Q2 2025 (Q&A)18 Mar 2026 - Double-digit new business growth and robust solvency, but net loss from market volatility.1828
Q2 202418 Mar 2026 - VNB up 16% and new business sales up 13% year-on-year, driven by broad segment growth.1828
Q3 202418 Mar 2026 - Delivered first net profit under IFRS 17, strong growth in all segments, and robust capital position.1828
Q4 202418 Mar 2026 - Q1 2025 new business CSM up 55% and APE up 46%, led by strong Asian market demand.1828
Q1 202518 Mar 2026